This company has been marked as potentially delisted and may not be actively trading. Harpoon Therapeutics (HARP) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock HARP Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Should You Count on MRK for Steady Passive Income?June 28, 2025 | msn.comDoes Merck Stock Have Room For Growth?April 29, 2025 | forbes.comTech Moves: Starbucks names CFO; Avanade bolsters C-suite; Tune Therapeutics gets CEOMarch 4, 2025 | msn.comUmoja Biopharma Announces Appointment of Dr. Luke Walker as Chief Medical OfficerJanuary 27, 2025 | markets.businessinsider.comSA Asks: Which biotechs are most likely to be acquired near-term?January 5, 2025 | msn.comUmoja Biopharma Appoints Scott Myers as Chairman of its Board of DirectorsNovember 21, 2024 | markets.businessinsider.comThe Harpoon Missile: A Great But Obsolete Weapon?October 20, 2024 | msn.comDaiichi Sankyo, Merck Phase 3 Lung-Cancer Study Meets Primary EndpointSeptember 17, 2024 | marketwatch.comRay Therapeutics Appoints Christopher Whitmore as Chief Financial OfficerSeptember 16, 2024 | finance.yahoo.comAntibody Drug-Conjugate Shows Promising Activity in Extensive-Stage SCLCSeptember 12, 2024 | msn.comMSK Team Identifies New Rare Small Cell Lung CancerSeptember 12, 2024 | msn.comT-cell targeting Candid Therapeutics launches with $370mSeptember 10, 2024 | finance.yahoo.comBig Pharma Stocks: Who’s Leading the Race and Who’s Slipping?August 22, 2024 | investing.comPharma Stock Roundup: LLY, NVO, BAYRY Q2 Earnings, MRK's New Deal & Other UpdatesAugust 9, 2024 | msn.comMerck to discontinue Phase 3 KeyVibe-008 trial based on recommendation of DMCAugust 8, 2024 | msn.comMerck Stops Lung Cancer Study For Keytruda Combo Due To Ineffective Results, Side EffectsAugust 8, 2024 | msn.comAmgen talks obesity drug ‘differentiation’; Servier brain cancer drug approved by FDAAugust 7, 2024 | finance.yahoo.comDaiichi Sankyo and Merck Enter into Global Development and Commercialization Agreement for MK-6070August 6, 2024 | finance.yahoo.comShould You Pick Merck Stock At $115 After A Q2 Beat?August 1, 2024 | forbes.comMerck shares fall 9% despite earnings beat, strong demand for top drugs like KeytrudaJuly 31, 2024 | msn.comHarpoon Brewery And Life Is Good Want To Offer Fans A New Summer StyleMay 27, 2024 | forbes.comAmgen Drug Wins US Approval for Type of Advanced Lung CancerMay 16, 2024 | msn.comIs Johnson & Johnson Stock A Better Pick Over Merck?May 14, 2024 | forbes.comViracta Therapeutics Appoints Faerm As CFOMay 14, 2024 | markets.businessinsider.comMerck and other pharma giants are bracing for competition to their blockbuster drugs. Here's how.May 8, 2024 | msn.comMerck raises 2024 profit forecast on surging sales of cancer drug KeytrudaApril 25, 2024 | msn.comHARP Apr 2024 20.000 putMarch 16, 2024 | finance.yahoo.comHARP Sep 2024 20.000 putMarch 16, 2024 | finance.yahoo.comShort Interest in Harpoon Therapeutics, Inc. (NASDAQ:HARP) Declines By 53.6%March 13, 2024 | marketbeat.comAnalysts Are Bullish on Top Healthcare Stocks: Biogen (BIIB), Merck & Company (MRK)March 13, 2024 | markets.businessinsider.comMerck completes acquisition of Harpoon TherapeuticsMarch 12, 2024 | msn.comHarpoon Therapeutics, Inc. (NASDAQ:HARP) Major Shareholder Buys $492,135,715.00 in StockMarch 12, 2024 | insidertrades.comMerck & Co., Inc. Acquires 21,397,205 Shares of Harpoon Therapeutics, Inc. (NASDAQ:HARP) StockMarch 11, 2024 | marketbeat.comHarpoon Therapeutics, Inc. (NASDAQ:HARP) Position Lessened by Kennedy Capital Management LLCMarch 11, 2024 | marketbeat.comHarpoon Therapeutics (Nasdaq:HARP) HeadlineTrading was temporarily halted for "HARP" at 07:03 PM with a stated reason of "News pending."...March 11, 2024 | marketbeat.comAnalysts Offer Insights on Healthcare Companies: Iovance Biotherapeutics (IOVA), Brainsway (BWAY) and Wave Life Sciences (WVE)March 7, 2024 | markets.businessinsider.comHarpoon Therapeutics ticks higher amid Nasdaq delisting notice for sale to MerckMarch 6, 2024 | msn.comAcadian Asset Management LLC Sells 69,040 Shares of Harpoon Therapeutics, Inc. (NASDAQ:HARP)March 6, 2024 | marketbeat.comHarpoon Therapeutics, Inc. (NASDAQ:HARP) Shares Sold by MPM Bioimpact LLCMarch 1, 2024 | marketbeat.comCitigroup Downgrades Harpoon Therapeutics (HARP)February 27, 2024 | msn.comAnalyst Scoreboard: 4 Ratings For Harpoon TherapeuticsFebruary 26, 2024 | markets.businessinsider.comHarpoon Therapeutics (NASDAQ:HARP) Rating Reiterated by CitigroupFebruary 26, 2024 | marketbeat.comHarpoon Therapeutics just downgraded at Citi, here's whyFebruary 24, 2024 | realmoney.thestreet.comFate of US Aid to Ukraine Package Discussed on Taiwan Trip, Lawmakers SayFebruary 23, 2024 | usnews.comMerck wins EU backing for Keytruda use in resectable lung cancerFebruary 23, 2024 | msn.comHARPOON THERAPEUTICS (5HTA.BE)February 23, 2024 | finance.yahoo.comHarpoon Therapeutics Inc. (5HTA.SG)February 23, 2024 | finance.yahoo.comStock (HARP), Short Interest ReportFebruary 22, 2024 | benzinga.comHarpoon Therapeutics, Inc. (NASDAQ:HARP) Short Interest Up 15.2% in JanuaryFebruary 16, 2024 | marketbeat.comAnalysts Are Bullish on Top Healthcare Stocks: Immunovant (IMVT), 4D Molecular Therapeutics (FDMT)February 13, 2024 | markets.businessinsider.com Get Harpoon Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for HARP and its competitors with MarketBeat's FREE daily newsletter. Email Address HARP Media Mentions By Week HARP Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HARP News Sentiment▼0.530.58▲Average Medical News Sentiment HARP News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HARP Articles This Week▼00▲HARP Articles Average Week Get Harpoon Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for HARP and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies PHXM News SXTPW News DRTSW News BCTXW News ENGNW News FBIOP News GOVXW News LEXXW News NTRBW News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:HARP) was last updated on 7/6/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredThe day and month stocks are most likely to crash nextGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | Sponsored140% Yields From Stocks Like Tesla? Here's How (July 4th Special)Imagine getting a 140% dividend from your investments. Even better? It works with big names like Tesla, ...Investors Alley | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump's ticking time bombA looming tariff deadline on July 9th could be the spark — but what’s buried inside a recent White House docum...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Harpoon Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Harpoon Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HARP Stock Alerts